Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT04549168 |
| Consolidated Lead Sponsor | Eisai |
| Therapeutic Condition Cohort | Neurology, Psychiatry, and Pain |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | COMPLETED |
| Registered Enrollment | 194 participants (ACTUAL) |
| Registered Start Date | 2020-11-06 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Xuanwu Hospital Capital Medical University | Beijing, China | Open Hospital Dossier -> |
| Guangdong Provincial People's Hospital | Guangzhou, China | Open Hospital Dossier -> |
| Nanfang Hospital of Southern Medical University | Guangzhou, China | Open Hospital Dossier -> |
| The First Hospital of Hebei Medical University | Shijiazhuang, China | Open Hospital Dossier -> |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Eisai across sibling Meru public-data platforms.
Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.